Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -47.75% is 69% above its 1-year average of -154.60%, near the high end of its 1-year range (-228.83%–-47.75%).
As of the fiscal period ended Tuesday, June 30, 2026. 69.12% above its 12-month average of -154.60%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -47.75%.
RETURN ON INVESTED CAPITAL (ROIC)
-47.75%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-154.60%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+69.12%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
-33.95%
vs the sector median at left
Polaryx Therapeutics, Inc. Common Stock
Market Cap
$104.68M
Return on Invested Capital (ROIC)
-47.75%
TTM Avg
-154.60%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$104.26M
Return on Invested Capital (ROIC)
41.64%
TTM Avg
-39.48%
3Y Avg
-25.23%
5Y Avg
-17.21%
Market Cap
$103.14M
Return on Invested Capital (ROIC)
-47.54%
TTM Avg
-30.79%
3Y Avg
-47.42%
5Y Avg
-44.72%
Market Cap
$106.52M
Return on Invested Capital (ROIC)
-92.16%
TTM Avg
-430.04%
3Y Avg
-259.02%
5Y Avg
-188.28%
Market Cap
$102.75M
Return on Invested Capital (ROIC)
-82.35%
TTM Avg
-77.56%
3Y Avg
-62.72%
5Y Avg
-68.20%
Market Cap
$106.93M
Return on Invested Capital (ROIC)
-73.94%
TTM Avg
-76.71%
3Y Avg
-67.16%
5Y Avg
-152.71%
Market Cap
$106.96M
Return on Invested Capital (ROIC)
-352.19%
TTM Avg
-1462.52%
3Y Avg
-874.13%
5Y Avg
-711.22%
Market Cap
$106.98M
Return on Invested Capital (ROIC)
-34.77%
TTM Avg
-10.04%
3Y Avg
-11.68%
5Y Avg
-11.21%
Market Cap
$107.09M
Return on Invested Capital (ROIC)
-101.30%
TTM Avg
-45.83%
3Y Avg
-127.78%
5Y Avg
-123.84%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Polaryx Therapeutics, Inc. Common Stock (PLYX) | $104.68M | -47.75% | -154.60% | N/A | N/A |
| Definitive Healthcare Corp. (DH)vs › | $104.26M | 41.64% | -39.48% | -25.23% | -17.21% |
| Black Diamond Therapeutics, Inc. (BDTX)vs › | $103.14M | -47.54% | -30.79% | -47.42% | -44.72% |
| Immunic, Inc. (IMUX)vs › | $106.52M | -92.16% | -430.04% | -259.02% | -188.28% |
| Anixa Biosciences, Inc. (ANIX)vs › | $102.75M | -82.35% | -77.56% | -62.72% | -68.20% |
| Vivani Medical, Inc. (VANI)vs › | $106.93M | -73.94% | -76.71% | -67.16% | -152.71% |
| Outlook Therapeutics, Inc. (OTLK)vs › | $106.96M | -352.19% | -1462.52% | -874.13% | -711.22% |
| Cumberland Pharmaceuticals Inc. (CPIX)vs › | $106.98M | -34.77% | -10.04% | -11.68% | -11.21% |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP)vs › | $107.09M | -101.30% | -45.83% | -127.78% | -123.84% |
| Apyx Medical Corporation (APYX)vs › | $107.17M | -6.84% | -23.14% | -32.81% | -31.36% |
ROIC
-47.7%
ROE
-62.6%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -47.75% |
| 2026-03-31 | -189.99% |
| 2025-12-31 | -162.43% |
| 2025-09-30 | -143.99% |
| 2025-06-30 | -228.83% |
